Comparative Study on the Therapeutic Outcomes of Enzalutamide Combined with Docetaxel Versus Docetaxel Alone in Metastatic Castration-Resistant Prostate Cancer Patients Following Sequential Androgen Receptor Pathway Targeted Therapy Failure

Name: Comparative Study on the Therapeutic Outcomes of Enzalutamide Combined with Docetaxel Versus Docetaxel Alone in Metastatic Castration-Resistant Prostate Cancer Patients Following Sequential Androgen Receptor Pathway Targeted Therapy Failure
Creator: figshare
Published: 2025-04-02 16:05:16
License: 暂无描述

DataCite Commons2025-04-02 更新2025-05-07 收录

下载链接：

https://figshare.com/articles/dataset/Comparative_Study_on_the_Therapeutic_Outcomes_of_Enzalutamide_Combined_with_Docetaxel_Versus_Docetaxel_Alone_in_Metastatic_Castration-Resistant_Prostate_Cancer_Patients_Following_Sequential_Androgen_Receptor_Pathway_Targeted_Therapy_Failure/28716245

下载链接

链接失效反馈

官方服务：

资源简介：

To evaluate the therapeutic effectiveness and adverse effects of combining enzalutamide with docetaxel versus using docetaxel alone in treating metastatic castration-resistant prostate cancer (mCRPC) that progresses after effective treatment with abiraterone followed by enzalutamide.

提供机构：

figshare

创建时间：

2025-04-02